Sumida et al. [64] showed a correlation between serum Trx levels and hepatic fat content in patients with fatty liver and proposed its usefulness in discriminating fatty liver from NASH. This evidence concerns the gene TXN and metabolic dysfunction-associated steatohepatitis.